Report Detail

Request for Sample of this report

Pharma & Healthcare Global Hyperimmune Globulins Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4653767
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Hyperimmune Globulins market size was valued at US$ 1992 million in 2024 and is forecast to a readjusted size of USD 3149 million by 2031 with a CAGR of 6.8% during review period.
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously. Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%. Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent. In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
The hyperimmune globulin market is primarily driven by the increasing prevalence of infectious diseases and the rising demand for immunoglobulin therapies. These therapies are crucial in treating immunodeficiency disorders and providing passive immunity against various pathogens, which fuels market growth. Additionally, advancements in plasma-derived therapies and increasing government initiatives for immunization programs contribute to market expansion.
However, the market faces significant challenges, such as the high cost of treatment and limited availability of plasma, which is a critical raw material for hyperimmune globulin production. Moreover, stringent regulatory requirements for product approval and potential side effects associated with immunoglobulin therapies can hinder market growth.
This report is a detailed and comprehensive analysis for global Hyperimmune Globulins market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hyperimmune Globulins market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Hyperimmune Globulins market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Hyperimmune Globulins market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Hyperimmune Globulins market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hyperimmune Globulins
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hyperimmune Globulins market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Hyperimmune Globulins market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Herpes Zoster Immune Globulin
Other
Market segment by Application
Government Institutions
Private Sector
Other
Major players covered
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hyperimmune Globulins product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hyperimmune Globulins, with price, sales quantity, revenue, and global market share of Hyperimmune Globulins from 2020 to 2025.
Chapter 3, the Hyperimmune Globulins competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hyperimmune Globulins breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Hyperimmune Globulins market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hyperimmune Globulins.
Chapter 14 and 15, to describe Hyperimmune Globulins sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hyperimmune Globulins Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Hepatitis B Immunoglobulins
    • 1.3.3 Rabies Immunoglobulins
    • 1.3.4 Tetanus Immunoglobulins
    • 1.3.5 Rho(D) Immunoglobulins
    • 1.3.6 Herpes Zoster Immune Globulin
    • 1.3.7 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hyperimmune Globulins Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Government Institutions
    • 1.4.3 Private Sector
    • 1.4.4 Other
  • 1.5 Global Hyperimmune Globulins Market Size & Forecast
    • 1.5.1 Global Hyperimmune Globulins Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Hyperimmune Globulins Sales Quantity (2020-2031)
    • 1.5.3 Global Hyperimmune Globulins Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 CSL Behring
    • 2.1.1 CSL Behring Details
    • 2.1.2 CSL Behring Major Business
    • 2.1.3 CSL Behring Hyperimmune Globulins Product and Services
    • 2.1.4 CSL Behring Hyperimmune Globulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 CSL Behring Recent Developments/Updates
  • 2.2 Grifols
    • 2.2.1 Grifols Details
    • 2.2.2 Grifols Major Business
    • 2.2.3 Grifols Hyperimmune Globulins Product and Services
    • 2.2.4 Grifols Hyperimmune Globulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Grifols Recent Developments/Updates
  • 2.3 Biotest
    • 2.3.1 Biotest Details
    • 2.3.2 Biotest Major Business
    • 2.3.3 Biotest Hyperimmune Globulins Product and Services
    • 2.3.4 Biotest Hyperimmune Globulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Biotest Recent Developments/Updates
  • 2.4 Kedrion
    • 2.4.1 Kedrion Details
    • 2.4.2 Kedrion Major Business
    • 2.4.3 Kedrion Hyperimmune Globulins Product and Services
    • 2.4.4 Kedrion Hyperimmune Globulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Kedrion Recent Developments/Updates
  • 2.5 CBPO
    • 2.5.1 CBPO Details
    • 2.5.2 CBPO Major Business
    • 2.5.3 CBPO Hyperimmune Globulins Product and Services
    • 2.5.4 CBPO Hyperimmune Globulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 CBPO Recent Developments/Updates
  • 2.6 Emergent (Cangene)
    • 2.6.1 Emergent (Cangene) Details
    • 2.6.2 Emergent (Cangene) Major Business
    • 2.6.3 Emergent (Cangene) Hyperimmune Globulins Product and Services
    • 2.6.4 Emergent (Cangene) Hyperimmune Globulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Emergent (Cangene) Recent Developments/Updates
  • 2.7 Kamada
    • 2.7.1 Kamada Details
    • 2.7.2 Kamada Major Business
    • 2.7.3 Kamada Hyperimmune Globulins Product and Services
    • 2.7.4 Kamada Hyperimmune Globulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Kamada Recent Developments/Updates
  • 2.8 CNBG
    • 2.8.1 CNBG Details
    • 2.8.2 CNBG Major Business
    • 2.8.3 CNBG Hyperimmune Globulins Product and Services
    • 2.8.4 CNBG Hyperimmune Globulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 CNBG Recent Developments/Updates
  • 2.9 Hualan Bio
    • 2.9.1 Hualan Bio Details
    • 2.9.2 Hualan Bio Major Business
    • 2.9.3 Hualan Bio Hyperimmune Globulins Product and Services
    • 2.9.4 Hualan Bio Hyperimmune Globulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Hualan Bio Recent Developments/Updates
  • 2.10 Shanghai RAAS
    • 2.10.1 Shanghai RAAS Details
    • 2.10.2 Shanghai RAAS Major Business
    • 2.10.3 Shanghai RAAS Hyperimmune Globulins Product and Services
    • 2.10.4 Shanghai RAAS Hyperimmune Globulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Shanghai RAAS Recent Developments/Updates
  • 2.11 Sichuan Yuanda Shuyang
    • 2.11.1 Sichuan Yuanda Shuyang Details
    • 2.11.2 Sichuan Yuanda Shuyang Major Business
    • 2.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Product and Services
    • 2.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates
  • 2.12 ADMA Biologics
    • 2.12.1 ADMA Biologics Details
    • 2.12.2 ADMA Biologics Major Business
    • 2.12.3 ADMA Biologics Hyperimmune Globulins Product and Services
    • 2.12.4 ADMA Biologics Hyperimmune Globulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 ADMA Biologics Recent Developments/Updates

3 Competitive Environment: Hyperimmune Globulins by Manufacturer

  • 3.1 Global Hyperimmune Globulins Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Hyperimmune Globulins Revenue by Manufacturer (2020-2025)
  • 3.3 Global Hyperimmune Globulins Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Hyperimmune Globulins by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Hyperimmune Globulins Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Hyperimmune Globulins Manufacturer Market Share in 2024
  • 3.5 Hyperimmune Globulins Market: Overall Company Footprint Analysis
    • 3.5.1 Hyperimmune Globulins Market: Region Footprint
    • 3.5.2 Hyperimmune Globulins Market: Company Product Type Footprint
    • 3.5.3 Hyperimmune Globulins Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hyperimmune Globulins Market Size by Region
    • 4.1.1 Global Hyperimmune Globulins Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Hyperimmune Globulins Consumption Value by Region (2020-2031)
    • 4.1.3 Global Hyperimmune Globulins Average Price by Region (2020-2031)
  • 4.2 North America Hyperimmune Globulins Consumption Value (2020-2031)
  • 4.3 Europe Hyperimmune Globulins Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Hyperimmune Globulins Consumption Value (2020-2031)
  • 4.5 South America Hyperimmune Globulins Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Hyperimmune Globulins Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Hyperimmune Globulins Sales Quantity by Type (2020-2031)
  • 5.2 Global Hyperimmune Globulins Consumption Value by Type (2020-2031)
  • 5.3 Global Hyperimmune Globulins Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Hyperimmune Globulins Sales Quantity by Application (2020-2031)
  • 6.2 Global Hyperimmune Globulins Consumption Value by Application (2020-2031)
  • 6.3 Global Hyperimmune Globulins Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Hyperimmune Globulins Sales Quantity by Type (2020-2031)
  • 7.2 North America Hyperimmune Globulins Sales Quantity by Application (2020-2031)
  • 7.3 North America Hyperimmune Globulins Market Size by Country
    • 7.3.1 North America Hyperimmune Globulins Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Hyperimmune Globulins Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Hyperimmune Globulins Sales Quantity by Type (2020-2031)
  • 8.2 Europe Hyperimmune Globulins Sales Quantity by Application (2020-2031)
  • 8.3 Europe Hyperimmune Globulins Market Size by Country
    • 8.3.1 Europe Hyperimmune Globulins Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Hyperimmune Globulins Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hyperimmune Globulins Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Hyperimmune Globulins Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Hyperimmune Globulins Market Size by Region
    • 9.3.1 Asia-Pacific Hyperimmune Globulins Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Hyperimmune Globulins Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Hyperimmune Globulins Sales Quantity by Type (2020-2031)
  • 10.2 South America Hyperimmune Globulins Sales Quantity by Application (2020-2031)
  • 10.3 South America Hyperimmune Globulins Market Size by Country
    • 10.3.1 South America Hyperimmune Globulins Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Hyperimmune Globulins Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hyperimmune Globulins Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Hyperimmune Globulins Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Hyperimmune Globulins Market Size by Country
    • 11.3.1 Middle East & Africa Hyperimmune Globulins Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Hyperimmune Globulins Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Hyperimmune Globulins Market Drivers
  • 12.2 Hyperimmune Globulins Market Restraints
  • 12.3 Hyperimmune Globulins Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hyperimmune Globulins and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hyperimmune Globulins
  • 13.3 Hyperimmune Globulins Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hyperimmune Globulins Typical Distributors
  • 14.3 Hyperimmune Globulins Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Hyperimmune Globulins. Industry analysis & Market Report on Hyperimmune Globulins is a syndicated market report, published as Global Hyperimmune Globulins Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Hyperimmune Globulins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo